Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron JL, Huang J, Camarata P, Lara LR, Dlugash R, McBee N, Eslami V, Hanley DF, Ziai WC; CLEAR III Trial Investigators.
Murthy SB, et al.
Neurology. 2017 Jul 25;89(4):355-362. doi: 10.1212/WNL.0000000000004155. Epub 2017 Jun 28.
Neurology. 2017.
PMID: 28659429
Free PMC article.
Clinical Trial.
Patients who had CSF shunts had similar odds of 180-day mortality, while survivors with shunts had increased odds of poor functional outcome, compared to survivors without shunts. CONCLUSIONS: Among patients with spontaneous IVH requiring emergency CSF diversion, those wit …
Patients who had CSF shunts had similar odds of 180-day mortality, while survivors with shunts had increased odds of poor functional …